# Hemarus LLC – FDA Inspection, Apr 30, 2024

Source: https://www.keypedia.com/records/fda_inspections/hemarus-llc/77674ace-ff97-4ad1-80bd-769e8481a0e7
Source feed: FDA_Inspections

> FDA inspection 1234618 of Hemarus LLC, April 30, 2024. Classification: Official Action Indicated (OAI). 12 citations under 21 CFR parts 606 and 630. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1234618
- Company Name: Hemarus LLC
- Inspection Date: 2024-04-30
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 12

## Related Documents

- FDA Inspection 1323742 - 2026-06-18
- FDA Inspection 1187347 - 2022-11-04

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/barbara-t-carmichael/4c451805-e327-450d-b2e5-48a40f6232fe)
- [Issuing Officer](https://www.keypedia.com/people/ivan-e-reyes/69bac3eb-f63c-45f0-8420-85a7e06b884a)
- [Investigator](https://www.keypedia.com/people/nerming-v-briones/b2d9e685-a627-4f9e-854c-0588865fd1b6)

Company: https://www.keypedia.com/companies/hemarus-llc/7e3cb278-9e15-4ba3-a74b-b27e6993381b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
